This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pre-Market Pulse: Dendreon, Novartis AG, Stryker, And Repros Therapeutics

LONDON, January 15, 2014 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Tuesday, January 14, 2014, the U.S. equity market finished on a positive note. The S&P 500 ended the day at 1,838.88, up 1.08%; the Dow Jones Industrial Average closed at 16,373.86, up 0.71%; and the NASDAQ Composite Index finished at 4,183.02, up 1.69%. The S&P 500 Health Care Sector Index gained 1.28% to close the session at 660.32; and the same has gained 10.62% in the previous three months and 6.32% in the last one month, outperforming the S&P 500, which has gained 7.53% and 3.58% during the respective periods. The major movers in the Health Care Sector included Dendreon Corp. (NASDAQ: DNDN), Novartis AG (NYSE: NVS), Stryker Corp. (NYSE: SYK), and Repros Therapeutics Inc. (NASDAQ: RPRX). All these companies are tracked by AAAResearchReports.com. Download free technical analysis and charting reports on DNDN, NVS, SYK, and RPRX now at:

http://www.aaaresearchreports.com/register/

On Tuesday, Dendreon Corp.'s stock closed the day at $3.30, up 1.23% from the previous day's closing price of $3.26. The company's shares vacillated between $3.21 and $3.40 during the trading session. A total of 5.05 million shares were traded, which is above the daily average volume of 4.66 million. The company's shares have surged 25.00% in the previous three months and 13.40% in the last three trading sessions, outperforming the S&P 500, which has gained 7.53% and 0.04% during the respective periods. Additionally, Dendreon Corp.'s stock is trading above its 50-day moving average of $2.93. Download free research on DNDN today by registering at:

http://www.AAAResearchReports.com/DNDN011514.pdf

Novartis AG's stock edged 0.44% higher on Tuesday, ending the day at $80.74, after oscillating between $80.39 and $80.94 during the trading session. A total of 0.89 million shares were traded, which is below the daily average volume 1.29 million. The company's shares have advanced 5.08% in the previous one month, outperforming the S&P 500, which has gained 3.58% during the same period. Moreover, Novartis AG's stock is trading near its 52-week high of $81.37 and also above its 50-day and 200-day moving averages of $78.60 and $74.88, respectively. Sign up and have access to our free report on NVS at:

http://www.AAAResearchReports.com/NVS011514.pdf

Shares in Stryker Corp. fluctuated between $77.48 and $78.40 before closing the Tuesday's trading session at $78.16, up 0.94%. A total of 1.57 million shares were traded, which is above the daily average volume of 1.36 million. The company's shares have gained 10.38% in the previous three months and 9.22% in the last one month, outperforming the S&P 500, which has gained 7.53% and 3.58% during the respective periods. Furthermore, shares in Stryker Corp. are trading near their 52-week high of $78.53 and also above their 50-day and 200-day moving averages of $74.28 and $69.73, respectively. Sign up and read the complimentary report on SYK at:

http://www.AAAResearchReports.com/SYK011514.pdf

On Tuesday, Repros Therapeutics Inc.'s stock closed the day at $20.43, up 1.79% from the previous day's closing price of $20.07. The company's shares vacillated between $19.86 and $20.57 during the trading session. A total of 0.21 million shares were traded, which is below the daily average volume of 0.50 million. The company's shares have gained 18.92% in the previous one month and 0.20% in the last three trading sessions, outperforming the S&P 500, which has gained 3.58% and 0.04% during the respective periods. Further, Repros Therapeutics Inc.'s stock is trading above its 50-day and 200-day moving averages of $17.21 and $19.35, respectively. The free report on RPRX can be downloaded by signing up now at:

http://www.AAAResearchReports.com/RPRX011514.pdf

----

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,727.71 +97.44 0.55%
S&P 500 2,104.31 +11.06 0.53%
NASDAQ 5,100.9420 +11.7360 0.23%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs